Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
Launched by PENN STATE UNIVERSITY · Feb 25, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on finding better ways to help state policymakers use scientific research when making decisions about preventing substance misuse, such as drug and alcohol abuse. The researchers are testing a specific approach called the Research-to-Policy Collaboration (RPC) Model in 30 states. The goal is to improve how research is used in creating laws and policies, which could lead to more effective programs that help prevent substance misuse in communities.
To participate in this trial, individuals must be state-level public officials, meaning they work in government roles that influence policies. If selected, participants will engage in activities designed to enhance their understanding and application of research evidence in their policymaking efforts. This trial is currently recruiting participants, and it aims to ensure that scientific information is better integrated into the creation of prevention programs, ultimately benefiting public health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • State-level public officials
- Exclusion Criteria:
- • Anyone who is not a state-level public official
About Penn State University
Penn State University is a leading research institution renowned for its commitment to advancing knowledge and improving health outcomes through innovative clinical trials. As a prominent sponsor of clinical research, the university leverages its diverse expertise across various medical fields to conduct rigorous studies aimed at evaluating new treatments, interventions, and healthcare strategies. With a strong emphasis on collaboration, ethical standards, and patient safety, Penn State University is dedicated to translating research findings into real-world applications that enhance the well-being of communities and contribute to the broader scientific landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
University Park, Pennsylvania, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported